Bridget Maturi

Burden of Spinal Muscular Atrophy (SMA) on Patients and Caregivers in Canada

Hugh J. McMillan, Brittany Gerber, Thomas E. Cowling et al. · Journal of Neuromuscular Diseases · 2021 · 62 citations · Full text

Medicine, Neurology, Health Services Research +10

Epidemiology, healthcare resource utilization and healthcare costs for spinal muscular atrophy in Alberta, Canada

Guanmin Chen, Behnam Sharif, Brittany Gerber et al. · Journal of Medical Economics · 2021 · 21 citations · Full text

Pharmacy, Health Sciences, Cost-effectiveness Analysis +16

Epidemiology and economic burden of Huntington’s disease: a Canadian provincial public health system perspective

Eileen Shaw, Michelle L. Mayer, Paul Ekwaru et al. · Journal of Medical Economics · 2022 · 21 citations · Full text

Public Health, Health Sciences, Pharmacoeconomics +16

PCN11 PHARMACOECONOMIC ANALYSES OF ERLOTINIB COMPARED WITH BEST SUPPORTIVE CARE (BSC) FOR THE TREATMENT OF RELAPSED NON-SMALL CELL LUNG CANCER (NSCLC) FROM THE CANADIAN PUBLIC HEALTH CARE PERSPECTIVE

Isabelle Côté, N. B. Leighl, Marlene Gyldmark et al. · Value in Health · 2006 · 16 citations · Full text

Pharmacy, Oncology, Pharmacoeconomics +7

Maintenance Therapy with Rituximab for Follicular Lymphoma Is Cost-Effective – A Canadian Perspective.

Bridget Maturi, Joseph Mıkhael, W. Dunlop et al. · Blood · 2006 · 12 citations

Medicine, Immunology, Oncology +4